Covid vaccine: Pfizer says new data shows one dose is 93% effective after 2 weeks
|The US drugmaker Pfizer Inc. urged a change in policy to single dosing of its covid vaccine, saying that the new data shows one dose is 93% effective after two weeks, almost as good as two doses, according to New England Journal of Medicine letters.
Meanwhile, Moderna Inc. said that the vaccine is good against all variants except probably the South African variant.
Market reaction
As markets turn cautious, digesting the latest surge in the US Treasury yields, the risk sentiment is taking a beat in the Asian trades this Thursday.
Mixed vaccine news also seems to weigh on the market mood.
The S&P 500 futures are down 0.25% on the day, trading near 3,918, as of writing.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.